{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Preoperative+Ketorolac", "query": { "intervention": "Preoperative Ketorolac" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 33, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Preoperative+Ketorolac&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-25T23:09:42.048Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07775248", "title": "Novel Extended-Release Bupivacaine Polymer for Sustained Pain Relief Following Total Knee Arthroplasty", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Osteoarthritis (OA) of the Knee" ], "interventions": [ { "name": "Periarticular Injection", "type": "DRUG" }, { "name": "Adductor Canal Block", "type": "DRUG" }, { "name": "Bupivacaine-Meloxicam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Henry Ford Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2025-02-11", "completion_date": "2026-10-20", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-09-25T23:09:42.048Z", "location_count": 1, "location_summary": "Grosse Pointe Farms, Michigan", "locations": [ { "city": "Grosse Pointe Farms", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07775248" }, { "nct_id": "NCT00576329", "title": "Topical 0.4% Ketorolac and Vitreoretinal Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Surgery" ], "interventions": [ { "name": "Ketorolac", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 76, "start_date": "2006-11", "completion_date": "2007-10", "has_results": false, "last_update_posted_date": "2014-05-14", "last_synced_at": "2026-09-25T23:09:42.048Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00576329" }, { "nct_id": "NCT04292392", "title": "Pain Levels and Opioid Usage in Three Nerve Block Cohorts in Primary TKA", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Knee Arthropathy" ], "interventions": [ { "name": "preop ACB, followed by Intra-articular block during TKA surgery", "type": "OTHER" }, { "name": "preop ACB+IPACK block", "type": "OTHER" }, { "name": "preop ACB+IPACK block, followed by Intra-articular block during TKA surgery", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Louisville", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "22 Years to 89 Years" }, "enrollment_count": 0, "start_date": "2020-04-06", "completion_date": "2020-09-30", "has_results": false, "last_update_posted_date": "2020-11-04", "last_synced_at": "2026-09-25T23:09:42.048Z", "location_count": 1, "location_summary": "Louisville, Kentucky", "locations": [ { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT04292392" }, { "nct_id": "NCT04495894", "title": "Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-small Cell Lung Cancer", "Renal Cell Carcinoma" ], "interventions": [ { "name": "Preoperative Ketorolac", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 68, "start_date": "2020-08-24", "completion_date": "2024-02-01", "has_results": true, "last_update_posted_date": "2025-03-04", "last_synced_at": "2026-09-25T23:09:42.048Z", "location_count": 4, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04495894" }, { "nct_id": "NCT02473198", "title": "Femoral Nerve Block Compared to Exparel in Total Knee Replacement", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Osteoarthritis", "Pain" ], "interventions": [ { "name": "Exparel", "type": "DRUG" }, { "name": "Femoral Nerve Block Bupivacaine", "type": "DRUG" }, { "name": "Toradol", "type": "DRUG" }, { "name": "Morphine Sulfate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The New England Baptist Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "73 Years", "sex": "ALL", "summary": "18 Years to 73 Years" }, "enrollment_count": 312, "start_date": "2014-01", "completion_date": "2017-02", "has_results": false, "last_update_posted_date": "2016-03-17", "last_synced_at": "2026-09-25T23:09:42.048Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02473198" }, { "nct_id": "NCT06681688", "title": "Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Cataract" ], "interventions": [ { "name": "Omidria, {0.3%-1% Intraocular Solution}, VIGAMOX {0.5% moxifloxacin hydrochloride}, Kenalog {0.4 ml, 10mg/ml, triamcinolone acetonide}", "type": "DRUG" }, { "name": "Ketorolac (0.5%) {Toradol}, moxifloxacin (0.5%) {VIGAMOX}, prednisolone acetate (1%) {Pred Forte}", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Inder Paul Singh, M.D.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 94, "start_date": "2024-07-10", "completion_date": "2025-08", "has_results": false, "last_update_posted_date": "2024-11-29", "last_synced_at": "2026-09-25T23:09:42.048Z", "location_count": 2, "location_summary": "Venice, Florida • Racine, Wisconsin", "locations": [ { "city": "Venice", "state": "Florida" }, { "city": "Racine", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT06681688" }, { "nct_id": "NCT03586934", "title": "Multimodal Analgesia in Shoulder Arthroplasty", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Shoulder Pain", "Opioid Use" ], "interventions": [ { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Celecoxib 200mg", "type": "DRUG" }, { "name": "Celecoxib 400 mg", "type": "DRUG" }, { "name": "Ropivacaine", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Acetaminophen Injectable Product", "type": "DRUG" }, { "name": "Oxycodone", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Morphine Injectable Solution", "type": "DRUG" }, { "name": "hydrocodone bitartrate and acetaminophen", "type": "DRUG" }, { "name": "Morphine", "type": "DRUG" }, { "name": "Oxycodone Hydrochloride", "type": "DRUG" }, { "name": "Meloxicam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rush University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2018-06-01", "completion_date": "2019-06-01", "has_results": false, "last_update_posted_date": "2021-09-28", "last_synced_at": "2026-09-25T23:09:42.048Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03586934" }, { "nct_id": "NCT04766996", "title": "PROUD Study - Preventing Opioid Use Disorders", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Anesthesia", "Opioid Use" ], "interventions": [ { "name": "Guided mindfulness exercises", "type": "BEHAVIORAL" }, { "name": "Self-administered aromatherapy", "type": "OTHER" }, { "name": "Baby aspirin", "type": "DRUG" }, { "name": "Tylenol/Acetaminophen", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Meloxicam", "type": "DRUG" }, { "name": "Prilosec", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Voltaren", "type": "DRUG" }, { "name": "Zofran", "type": "DRUG" }, { "name": "Pepcid", "type": "DRUG" }, { "name": "Reglan", "type": "DRUG" }, { "name": "Versed", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" }, { "name": "Propofol", "type": "DRUG" }, { "name": "Ancef", "type": "DRUG" }, { "name": "Tranexamic Acid (TXA)", "type": "DRUG" }, { "name": "Decadron", "type": "DRUG" }, { "name": "Bupivacaine hydrochloride", "type": "DRUG" }, { "name": "Toradol", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "OTHER", "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 57, "start_date": "2021-05-17", "completion_date": "2021-12-27", "has_results": true, "last_update_posted_date": "2023-06-22", "last_synced_at": "2026-09-25T23:09:42.048Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04766996" }, { "nct_id": "NCT03331315", "title": "Toradol v. Celecoxib for Postoperative Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pain, Postoperative" ], "interventions": [ { "name": "Celecoxib", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Michael Ulm, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 170, "start_date": "2013-09-01", "completion_date": "2017-01-01", "has_results": true, "last_update_posted_date": "2023-12-07", "last_synced_at": "2026-09-25T23:09:42.048Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT03331315" }, { "nct_id": "NCT07840183", "title": "Epidural Analgesia Versus Opioid-sparing Analgesia for Open Ventral Hernia Repair With Transversus Abdominis Release", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Ventral Hernia", "Ventral Hernia Repair", "Postoperative Pain" ], "interventions": [ { "name": "Bupivicaine", "type": "DRUG" }, { "name": "Fentanyl", "type": "DRUG" }, { "name": "Thoracic epidural analgesia", "type": "DEVICE" }, { "name": "Hydromorphone", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "magnesium sulfate", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Gabapentin", "type": "DRUG" }, { "name": "Cyclobenzaprine", "type": "DRUG" }, { "name": "transversus abdominis plane block", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "DEVICE", "PROCEDURE" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 40, "start_date": "2026-09-18", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2026-09-24", "last_synced_at": "2026-09-25T23:09:42.048Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07840183" } ] }